Importantly, rescue experiments where LRPPRC overexpression reversed the malignant phenotypes of LARS knockdown further corroborate our hypothesis of a LARS–LRPPRC functional axis in DLBCL pathogenesis. The gene discussed is LARS1; the disease is diffuse large B-cell lymphoma.